Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker

Chronic graft-versus-host disease (cGvHD) is a major complication after allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an immunotherapy treatment for cGvHD, although suitable response biomarkers are lacking. We analyzed data from six cGvHD patients undergoing EC...

Full description

Saved in:
Bibliographic Details
Published in:Future science OA 2020-09, Vol.6 (8), p.FSO623-FSO623
Main Authors: Lopes, Sérgio Machado, Roncon, Susana, Pinho, Ana Catarina, Bordalo, Filipa, Antunes, Luís, Campilho, Fernando, Campos, António, Costa-Pereira, Altamiro
Format: Article
Language:English
Subjects:
ECP
extracorporeal photopheresis
GvHD
immunotherapy
Short Communication
Treg
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic graft-versus-host disease (cGvHD) is a major complication after allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) is an immunotherapy treatment for cGvHD, although suitable response biomarkers are lacking. We analyzed data from six cGvHD patients undergoing ECP at a reference center from 826 to 2866 days. Circulating Tregs were enumerated, patient’s clinical evolution, immunosuppression dose and adverse events (AEs) registered. We observed an increase in Tregs, a decrease in immunosuppression dosage and symptoms improvement. Mild AEs occurred at a very low rate. In these patients, the improvement of cGvHD, with low AEs, confirms a place for ECP as treatment. Improvements were accompanied by an increase in circulating Tregs, suggesting their role as a biomarker. Hematopoietic stem cell transplant is a lifesaving treatment, involving collecting blood-forming cells from a healthy donor and infusing them into a patient. Donor immune cells may attack patient tissues causing severe complications, including death (graft-versus-host disease [GvHD]). Primary treatment for GvHD are steroids. Extracorporeal photopheresis (ECP) is an alternative treatment that induces immunological tolerance, in part, due to Treg. We studied both clinical response and circulating Treg in six patients treated with ECP for up to 8 years. ECP responding patients had less GvHD, reduced the dose of steroids and increased the number of Treg.
ISSN:2056-5623
2056-5623
DOI:10.2144/fsoa-2020-0107